Open Access

Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer

  • Authors:
    • Peipei Xu
    • Xiaotian Xia
    • Zhili Yang
    • Yuan Tian
    • Jianzhong Di
    • Minggao Guo
  • View Affiliations

  • Published online on: August 16, 2017     https://doi.org/10.3892/etm.2017.4940
  • Pages: 3720-3726
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tectonic family member 1 (TCTN1) is one of the tectonic family members, and a regulator of the hedgehog signaling pathway, which has been studied in various cancer types, including prostate and pancreatic cancer. However, its function in thyroid cancer has not been well documented. Therefore, the present study investigated the function of TCTN1 in thyroid cancer using a loss‑of‑function assay. Lentivirus‑mediated RNA interference was applied to downre­gulate TCTN1 in the thyroid cancer cell lines, CAL62 and 8305C. A series of functional properties, including cell viability, colony formation, cell cycle and apoptosis were determined using MTT, colony formation assay and flow cytometry analyses, respectively. The results demonstrated that lentivirus‑medicated RNAi could specifically suppress the expression of TCTN1 at the mRNA and protein levels in CAL62, and 8305C cells. Knockdown of TCTN1 inhibited cell growth and proliferation via inducing S phase arrest, and apoptosis. Mechanistically, the S phase arrest was accompanied by the upregulation of cyclin dependent kinase 2, cyclin A2 and downregulation of cyclin B1. Knockdown of TCTN1 induced apoptosis through increasing the expression of Bcl2‑associated agonist of cell death, cleaved caspase‑3 and poly(ADP‑ribose)polymerase, and decreasing apoptosis regulator Bcl‑2 expression. The current study highlights the essential role of TCTN1 in promoting thyroid cancer cell proliferation, and its knockdown may serve as a potential therapeutic treatment for thyroid cancer.

Related Articles

Journal Cover

October-2017
Volume 14 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu P, Xia X, Yang Z, Tian Y, Di J and Guo M: Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer. Exp Ther Med 14: 3720-3726, 2017
APA
Xu, P., Xia, X., Yang, Z., Tian, Y., Di, J., & Guo, M. (2017). Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer. Experimental and Therapeutic Medicine, 14, 3720-3726. https://doi.org/10.3892/etm.2017.4940
MLA
Xu, P., Xia, X., Yang, Z., Tian, Y., Di, J., Guo, M."Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer". Experimental and Therapeutic Medicine 14.4 (2017): 3720-3726.
Chicago
Xu, P., Xia, X., Yang, Z., Tian, Y., Di, J., Guo, M."Silencing of TCTN1 inhibits proliferation, induces cell cycle arrest and apoptosis in human thyroid cancer". Experimental and Therapeutic Medicine 14, no. 4 (2017): 3720-3726. https://doi.org/10.3892/etm.2017.4940